Multiple PIP2 binding sites in Kir2.1 inwardly rectifying potassium channels  by Soom, Malle et al.
Multiple PIP2 binding sites in Kir2.1 inwardly rectifying
potassium channels
Malle Sooma, Roland Scho«nherra, Yoshihiro Kubob, Cornelia Kirschc, Reinhard Klingerc,
Stefan H. Heinemanna;*
aMolecular and Cellular Biophysics, Medical Faculty of the Friedrich Schiller University Jena, Drackendorfer StraMe 1, D-07747 Jena, Germany
bDepartment of Physiology, Tokyo Medical and Dental University, Graduate School and Faculty of Medicine, Yushima 1-5-45, Bunkyo-ku,
Tokyo, Japan
cInstitute for Biochemistry, Medical Faculty of the Friedrich Schiller University Jena, Nonnenplan 2, D-07743 Jena, Germany
Received 24 November 2000; accepted 8 January 2001
First published online 23 January 2001
Edited by Gunnar von Heijne
Abstract Inwardly rectifying potassium channels require bind-
ing of phosphatidylinositol-4,5-bisphosphate (PIP2) for channel
activity. Three independent sites (aa 175^206, aa 207^246, aa
324^365) were located in the C-terminal domain of Kir2.1
channels by assaying the binding of overlapping fragments to
PIP2 containing liposomes. Mutations in the first site, which
abolished channel activity, reduced PIP2 binding of this fragment
but not of the complete C-terminus. Point mutations in the third
site also reduced both, channel activity and PIP2 binding of this
segment. The relevance of the third PIP2 binding site provides a
basis for the understanding of constitutively active Kir2
channels. ß 2001 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Inwardly rectifying potassium channels (Kir channels) play
an important role in regulating cell membrane excitability.
They stabilize the resting membrane potential and mediate
K transport across membranes. These channels are com-
posed of four subunits, each comprising two transmembrane
segments (Fig. 1). Since they have no intrinsic gating struc-
tures like voltage-gated K channels, the open-probability of
these channels is regulated in indirect ways such as by the
voltage-dependent channel block by intracellular cations, by
association with GTP-binding proteins or with ATP binding
sulfonyl-urea receptors (for review see [1]). In addition, re-
cently it has been shown that these channels, like some other
ion channels and transporters, are regulated by the membrane
phospholipid phosphatidylinositol-4,5-bisphosphate (PIP2) [2].
PIP2 is a quantitatively minor membrane component,
although its local concentration may be relatively high. It is
a key signaling phospholipid, its hydrolysis by PLC as well as
its phosphorylation by PI3 kinases generates important sec-
ond messengers. PIP2 itself plays an important role in such
processes as the organization of actin cytoskeleton and vesic-
ular transport [3,4].
Biochemical experiments have demonstrated that PIP2
binds directly to Kir channels [5]. Apparently, bound PIP2
is required to stabilize the open state. The activity of Kir2.1
(IRK1) channels seems to depend only on the presence of
PIP2 in the membrane [6,7]. Other Kir channels have addi-
tional regulators that in£uence their dependence on PIP2.
Kir1.1 (ROMK1) channels are regulated by protein kinase
A through phosphorylation that seems to enhance the inter-
action of these channels with PIP2 [8]. Kir3.1/4 (GIRK1/4)
channels are regulated by the LQ-complex of GTP-binding
proteins (GLQ) and intracellular Na. Both regulatory mole-
cules possibly strengthen the interaction of the channel with
PIP2 [5,9]. PIP2 also reduces the ATP-sensitivity of KATP
channels (Kir6.x) [10^12]. These ¢ndings show that PIP2
may serve as a ¢nal regulator of several Kir channel types,
coupling their activity to cellular signaling pathways.
The molecular mechanism of PIP2-dependent regulation of
Kir channels is hypothesized as follows: the negatively
charged phosphate groups of the lipid interact with positively
charged amino acids in the Kir protein. Since PIP2 interacts
probably with all Kir channels it seems likely that these pos-
itively charged residues are somehow conserved. A good can-
didate for such a conserved PIP2 binding site is the cytoplas-
mic region distal of the second transmembrane segment
(residues 175^206 in Kir2.1, sections C1^C2 in Fig. 1), con-
taining a stretch of positively charged amino acid residues
(PKKR motif, residues 186^189). The arginine residue R189
within this region is highly conserved among the members of
the Kir family. Mutations of the homologous arginines in
Kir1.1, Kir6.2, and Kir5.1 signi¢cantly in£uence the e¡ect
of PIP2 [5,11,13].
How does a well-conserved binding site explains the obser-
vation that some channels only require PIP2, whereas others
need additional factors to stabilize the interaction of PIP2
with the channel? Interestingly, PIP2 was found to bind
more weakly to the C-terminus of Kir3.1 than to the C-ter-
minus of Kir2.1 [5]. The Kir2.1 region from amino acid res-
idues 206^245 has been identi¢ed to be important for its high-
er PIP2 a⁄nity. R218 and R228 and also L222 within this
region are required for the channel^PIP2 interactions (Fig.
1) [7,14]. These studies highlight the relevance of regions apart
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from the PKKR motif, but still leave several open questions.
Is the region 206^245 in Kir2.1 a modulator of the PKKR
binding site or does it form a second, independent binding
site? How many binding sites should we consider for Kir2.1
and other channels? Also the direct role of R189 and other
residues within the Kir2.1 PKKR motif for the Kir2.1^PIP2
interaction has not yet been shown.
2. Materials and methods
2.1. Molecular biology and recombinant proteins
The full-length mouse Kir2.1 (accession NM008425) was subcloned
into pBluescript KS (Stratagene, La Jolla, CA, USA). Point mutations
were generated by overlap extension PCR [15]. All the constructs were
veri¢ed by sequencing. Capped mRNA was synthesized in vitro with
T3 RNA polymerase (mMessage mMachine kit, Ambion, Austin, TX,
USA).
To generate the glutathione S-transferase (GST) fusions of Kir2.1,
the relevant gene fragments were generated as PCR products £anked
by BamHI and XhoI restriction sites and cloned in-frame with the
GST-encoding sequence in pGEX-5x-2 (Amersham-Pharmacia
GmbH). Expression of fusion proteins and GST alone was induced
by 0.1 mM IPTG in Escherichia coli BL-21. Bacterial cultures were
grown at 22‡C for 4^16 h, depending on the length of the constructs.
The proteins were puri¢ed using glutathione^4B-Sepharose beads as
described by the manufacturer. The purity and concentration of the
proteins was estimated on an SDS^PAGE gel together with a series of
BSA dilutions with known concentration. The samples were diluted to
0.4^0.8 mg/ml of the GST-fused protein in a 50% Sepharose slurry.
Sepharose with immobilized proteins was stored at 320‡C in protein
storage bu¡er (in mM: 50 HEPES, 50 NaCl, 5 MgCl2, 1 DTT pH 7.4,
50% glycerol). For PIP2 binding assays the proteins were washed three
times with lipid binding bu¡er (in mM: 10 HEPES, 100 KCl, pH 7.4).
The cloning and expression of GST fusion of full-length phospha-
tidylinositide 3-kinase Q (PI3KQ, residues 4^1068) has been published
[16]. The fusion protein was expressed in Sf9 cells during 3 days after
transfection. The cells were harvested and resuspended in lysis bu¡er
(in mM: 50 Tris, 150 NaCl, 5 EDTA, 50 NaF, 2 PMSF, 10 benza-
midine, 1 sodium orthovanadate, 0.02 leupeptin, pH 7.5, 1% (w/w)
Triton X-100). The GST^PI3KQ fusion protein was bound to gluta-
thione^4B-Sepharose and washed three times in lysis bu¡er.
2.2. Electrophysiological measurements
Stage V oocytes were prepared from Xenopus laevis as described
previously [17] and 50 nl of mRNA (200^250 ng/Wl) were injected.
Currents were measured at 20^23‡C, 20^24 h after injection with a
two-electrode voltage clamp (Turbo-TEC 10CD ampli¢er, NPI elec-
tronic, Tamm, Germany). The bath solution contained (in mM): 90
KCl, 3 MgCl2, 10 HEPES (pH 7.2 with KOH). Experiment control
including pulse generation and data recording was performed with
Pulse+PulseFit software (HEKA Elektronik, Lambrecht, Germany).
2.3. Preparation of liposomes
Mixed liposomes were prepared from PIP2 (from bovine brain,
Sigma), phosphatidylcholine (PC) (from chicken egg, Sigma) and
rhodamine-phosphatidylethanolamine (Rh-PE, Avanti Polar Lipids,
Alabaster, AL, USA) that was used for £uorescent labeling of lipo-
somes. Phospholipids dissolved in chloroform:methanol:H2O:1 N
HCl (20:9:1:10) were mixed to obtain the desired phospholipid com-
position of 2, 5, 10, 20, and 35 mol percent PIP2 and 97, 94, 89, 79,
and 64 mol percent PC, respectively. Rh-PE ratio was always 1 mol
percent. Control liposomes without PIP2 were taken to determine
PIP2-independent binding. Phospholipid mixtures were dried under
N2 ; lipid binding bu¡er was added to obtain a phospholipid concen-
tration of 1 mg/ml and the lipid ¢lm was dissolved by homogenizing
and vortexing. The mixture was left at room temperature for 30 min,
then homogenized and frozen at 380‡C for 15 min, followed by
sonication on ice (three times for 2 min with 1 min break). The
resulting sonicate was centrifuged and the supernatant containing
small unilamellar vesicles was used for binding assays with gluta-
thione^Sepharose immobilized proteins.
2.4. PIP2 binding assay
For performing PIP2 binding assays 0.1 ml of gluthathione^4B-
Sepharose with immobilized GST-fusion proteins or GST alone (40^
80 Wg protein/assay) were mixed with 0.1 ml of £uorescently labeled
liposomes and incubated with agitation at 37‡C for 1 h. Sepharose
was spun down and washed three times with lipid binding bu¡er.
Liposome binding to the immobilized proteins was quanti¢ed by £uo-
rescence measurement in 96-well plates (Fluoroscan II, Laborsystems
GmbH, Frankfurt, Germany) using an excitation and emission wave-
length of 390 nm and 590 nm, respectively. The mean £uorescence
value of two specimens was calculated for every sample. In addition,
the £uorescence of liposomes prepared in every experiment was mea-
sured. The data obtained for the protein samples mixed with di¡erent
liposomes and in di¡erent experiments were corrected by the ratio of
the liposome’s £uorescence. The resulting values were termed ‘£uores-
cence in arbitrary units’ (a.u.), re£ecting PIP2 binding of each protein
sample.
3. Results and discussion
3.1. Mutations in the PKKR motif reduce the expression of
functional Kir2.1 channels
To determine the physiological signi¢cance of the PKKR
motif in Kir2.1 channels, we tested the e¡ects of the following
mutations in this motif on the functional expression of Kir2.1
in Xenopus oocytes: P186A, K188Q, R189Q, and
K188QbR189Q. As shown in Fig. 2A, oocytes expressing mu-
tant channels showed smaller currents than those expressing
the wild-type channels. At 3100 mV the wild-type showed an
average current of 36.2 þ 1.0 WA (mean þ S.E.M.). Mutant
P186A yielded 31.4 þ 0.4 WA and mutant K188Q only
30.09 þ 0.05 WA. Mutants R189Q and K188QbR189Q yielded
no Kir-speci¢c current at all. Thus, the studied mutations
in the PKKR motif reduce the expression of functional
Kir2.1 channels in the following order: K188QbR189Q,
R189QsK188QsP186Aswild-type.
Fig. 1. Schematic representation of the Kir2.1 protein. Numbers indicate the amino acid positions. M1, M2 ^ transmembrane domains; P ^
pore domain; N1, C1^C8 ^ sections of Kir2.1 used in this study. Bottom: Distribution of positively (black) and negatively (white ovals)
charged residues. Numbers indicate residues that have been tested for PIP2 binding in this study and by [7] (gray). The hydrophobic residues
that have been tested for their in£uence on PIP2 binding are indicated as gray ovals.
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3.2. E¡ect of mutations in the PKKR motif on
Kir2.1^PIP2 binding
To correlate the e¡ects of the mutations on Kir2.1 current
and their binding to PIP2 we measured PIP2 binding of the
corresponding GST-fused proteins. As a control we tested the
binding of GST alone and GST^PI3KQ, which is known to
use PIP2 as one of its substrates [18], to the liposomes con-
taining di¡erent concentrations of PIP2 (Fig. 2B). At 35 mol
percent PIP2 the £uorescence value for GST was 0.34 þ 0.17
(mean þ S.D.), and for GST^PI3KQ 3.9 þ 1.2. Therefore, we
chose as a threshold value for PIP2 binding detection 1 arbi-
trary £uorescence unit, which is about the GST value plus
three standard deviations. In the following experiments we
considered all £uorescence values below 1 as absence of
PIP2 binding.
In comparison with GST and GST^PI3KQ we now tested
the whole C-terminus of Kir2.1 (C1^8) in the wild-type form
and containing the single-site mutation K188Q in the PKKR
motif (Fig. 2C). In an independent experiment the PIP2 bind-
ing to C1^8 was compared with a fragment lacking the PKKR
motif (C2^8) (Fig. 2D). In both cases we did not ¢nd qual-
itative changes in PIP2 binding compared to the wild-type C1^
8 fragment. In other words, neither the point mutation in the
PKKR motif, nor the complete absence of this region abol-
ished in vitro PIP2 binding to the Kir2.1 C-terminus. This
strongly suggests that other PIP2 binding regions must exist
in the Kir2.1 C-terminus, compensating for the inactivation of
the PKKR motif and making it impossible to detect di¡er-
ences in PIP2 binding in the background of the full-length C-
terminus.
Therefore, short C-terminal segments (C1^2) of the wild-
type and mutants were assayed with liposomes containing 0,
5, and 35 mol percent PIP2 (Fig. 2E). The wild-type fragment
was binding PIP2 already at 5 mol percent PIP2. At the same
concentration, K188QbR189Q showed almost no binding.
PIP2 binding of mutants P186A and K188Q was stronger,
but still below threshold. Mutant R189Q was signi¢cantly
binding PIP2, but about 1.5 times weaker than the wild-
type. At 35 mol percent PIP2 all of the constructs were bind-
ing PIP2 to a signi¢cant degree, so we could not distinguish
them in the qualitative PIP2 binding assay.
These experiments showed that the mutations decrease the
PIP2 a⁄nity of the region C1^2 in the following order:
K188QbR189QsP186A, K188QsR189Qswild-type. The
reduction of PIP2 binding could be a basis for the physiolog-
ical e¡ect of these mutations on Kir2.1 expression, although
the level of inhibition of Kir2.1 currents and PIP2 binding
does not correlate in all cases. Such correlation is observed
for mutants K188Q and K188QbR189Q, as they both lead to
signi¢cant reduction in Kir2.1 expression and PIP2 binding
in vitro. In the case of mutants P186A and R189Q the situa-
tion is reversal. Mutant P186A still allows for formation
of functional channels, but signi¢cantly reduces PIP2 binding
in vitro. Mutant R189Q completely abolishes Kir2.1 expres-
sion in oocytes, but binds PIP2 containing liposomes. This
indicates the existence of factors that could in£uence the bio-
Fig. 2. Evaluation of the PKKR motif for channel expression and PIP2 binding. A: E¡ects of point mutations in the PKKR-motif on the ex-
pression of Kir2.1 channels. Left: Current traces in response to voltage ramps (3100 to +50 mV in 2 s) from oocytes expressing wild-type (wt)
and the mutants P186A, K188Q, R189Q, and K188QbR189Q. Right: Box plots representing the statistics for the currents measured at 3100
mV. Linear leak correction was performed assuming that the current at +50 mV was leakage current with a reversal potential of 0 mV; n indi-
cates the number of oocytes. The center-line indicates the median, the boxes indicate the second and third quartile; whiskers and asterisks indi-
cate extreme values and outliers, respectively. B: Averaged binding data of GST alone and GST^PI3KQ (PI3KQ) to liposomes as a function of
the PIP2 concentration. Error bars indicate þ S.D., the dashed line the threshold for PIP2 binding. C^E: Independent PIP2 binding determina-
tions to the indicated constructs. In C and D data are shown for liposomes containing 35 mol percent PIP2 (dark gray) and for liposomes
without PIP2 (white). In E, additional experiments at 5 mol percent PIP2 (light gray) are shown.
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chemical characteristics of the PIP2 binding region C1^2 in
vivo.
3.3. Kir2.1 has three C-terminal PIP2 binding regions
These data suggested that additional PIP2 binding regions
could exist in the C-terminal part of Kir2.1 channels, and, in
fact, the region between aa 206 and 245 had been already
shown to be important for the high PIP2 a⁄nity of Kir2.1
[7]. For a further screen of the Kir2.1 C-terminus for minimal
PIP2 binding sites we constructed GST-fusion proteins with
overlapping Kir2.1 fragments. Region C4^8 (Fig. 3B) that
lacks the putative PIP2 binding region C3 still bound PIP2
containing liposomes. Judging from the distribution of
charged amino acids in the Kir2.1 C-terminus (Fig. 1) we
suspected that there could be one more PIP2 binding site in
the region C7.
Fig. 3A^C shows data from three independent experiments,
in which overlapping C-terminal fragments were tested for
PIP2 binding. Assays were performed at 35 mol percent
PIP2 to distinguish better between PIP2 binding and not bind-
ing regions. The GST-fused segment N1 (see Fig. 1) was used
as a control ; consistent with the data reported by others [5] it
bound PIP2 below threshold (Fig. 3C, leftmost bar). GST^
PI3KQ usually showed a stronger binding to the control lipo-
somes without PIP2 than the Kir2.1 fusions, re£ecting its low-
er speci¢city towards phospholipids. Two Kir2.1 fragments,
C5^6 and C5^7, also bound unspeci¢cally to the control lipo-
somes (Fig. 3C). Possibly, in these short fragments the hydro-
phobic segment C5 in£uenced the lipid binding more than in
the longer C5 containing constructs. Therefore, we judged
upon PIP2 a⁄nity of these proteins by the di¡erence between
binding to control and experimental (PIP2 containing) lipo-
somes. For the fragment C5^6 this di¡erence was 0.4 and for
C5^7 2.2 a.u., so we considered them as not binding and
binding PIP2, respectively. For comparison, the equivalent
values for GST and C5^8 were, 0.2 and 1.5 a.u., respectively.
Several regions bound PIP2 signi¢cantly over the threshold.
The summary of PIP2 binding data from all experiments is
given in Fig. 3D. The shortest PIP2 binding regions other than
C1^2 were C3 (207^246) and C7 (324^365). In the study of [7]
regions 246^270 and 292^310 could not been tested for their
importance for PIP2 binding. According to our data the frag-
ments containing these regions (C4, C5^6) do not bind PIP2,
but the latter one may in£uence PIP2 binding by region C7.
Indeed, some fragments containing this last PIP2 binding site
(C6^8 and C7^8) did not show PIP2 binding, whereas other
Fig. 3. Identi¢cation of PIP2 binding domains. A^C: Each panel shows the data from one PIP2 binding experiment. The labeling of the protein
constructs and liposomes is as in Fig. 2. D: Summary of the data from experiments on in vitro PIP2 binding of GST-fused C-terminal Kir2.1
fragments. Black bars indicate fragments that bind to liposomes containing 35 mol percent PIP2 above the threshold; white bars indicate frag-
ments without signi¢cant PIP2 binding.
Fig. 4. Comparison of three PIP2 binding sites. A: Binding of GST
fusion proteins was assayed as a function of PIP2 concentration
(mean þ S.E.M.). B: In£uence of mutation R343QbK346Q on PIP2
binding. The error bars indicate S.E.M. values for at least two inde-
pendent experiments. C: Box plots representing the statistics for the
currents measured at 3100 mV in oocytes expressing the wild-type
and the mutant R343QbK346Q. Data are presented as in Fig. 2.
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fragments (C5^8, C5^7, and C6^7) did. Thus, C8 has a neg-
ative e¡ect on PIP2 binding by fragments C7 and C6^7. This
can be explained by the high density of negatively charged
residues in this region preventing electrostatic binding be-
tween the positive charges in the region C7 and PIP2. The
region C5 antagonizes this e¡ect possibly due to its hydro-
phobicity that enhances the protein^lipid interactions when
present in the constructs.
3.4. Characterization of the third PIP2 binding region
We further characterized the three PIP2 binding regions by
measuring their a⁄nity to liposomes containing di¡erent PIP2
concentrations (Fig. 4A). Fragments C1^2 and C3 bound
PIP2 already at 5 mol percent PIP2 and reached their maximal
PIP2 a⁄nity at 20 mol percent. Thus, C3 harbors an inde-
pendent binding site that binds PIP2 in vitro with almost the
same a⁄nity as the PKKR containing region C1^2. PIP2
binding by the distal fragment C7 was weaker. At 5 and 20
mol percent PIP2, the binding was below the threshold; only
at 35 mol percent PIP2 it almost reached the PIP2 binding
strength of the ¢rst two fragments. The weaker PIP2 a⁄nity
may re£ect a higher number of negatively charged residues in
this region. These data characterize fragments C1^2 and C3 as
‘strong’ and fragment C7 as ‘weak’ in vitro PIP2 binding sites.
In the study of Zhang and colleagues [7] segments 316^341
and 342^366, which split the region C7 in two, were shown to
be not important for high-a⁄nity PIP2 binding. This could
mean that an intact C7 region is necessary for PIP2 binding
and/or that this region is indeed a low-a⁄nity PIP2 binding
segment.
The functional relevance of the third PIP2 binding region in
Kir2.1 was tested by the double mutation R343QbK346Q. As
shown in Fig. 4B, this mutation signi¢cantly reduces in vitro
PIP2 binding of C7 at 35 mol percent PIP2. Upon expression
in Xenopus oocytes, it gave almost no current in comparison
with wild-type Kir2.1 (30.58 þ 0.34 WA and 338.6 þ 3.4 WA,
respectively) (Fig. 4C). These data show that R343 and K346
are critical for PIP2 binding of C7 in vitro. Furthermore, they
suggest that the additional PIP2 binding site in C7 is necessary
for Kir2.1 function.
All three PIP2 binding segments of Kir2.1 are conserved
among the members of the Kir2 subfamily. Comparison of
these segments does not reveal close sequence homology or
even a de¢ned amino acid motif. However, a common feature
of the identi¢ed regions is the presence of multiple positive
charges interspersed with aromatic or aliphatic amino acids.
These characteristics seem to be a conserved principle among
proteins that bind phosphoinositides, but do not involve
pleckstrin homology (PH) domains, such as phospholipase
D, synaptotagmin or gelsolin [19,20]. Our data support the
idea that phosphoinositide binding depends not only on the
electrostatic, but also on hydrophobic interactions. The rele-
vance of Kir2.1 mutations P186A (this study) and L222I [7]
for PIP2 binding and channel expression suggests that the
mechanism of protein^phosphoinositide interaction could be
even more complex.
The identi¢cation of multiple PIP2 binding sites in Kir2.1
sheds light on the constitutive activity of this channel. It can
be hypothesized that some of these PIP2 interaction sites are
not functional in the regulated members of the Kir family,
and thus, additional factors are required to stabilize the active
channel conformation. Interestingly, Kir2.1 region 316^341,
which overlaps the third binding site 324^365, has been shown
to cause formation of a GLQ-insensitive Kir3.4 channel, when
replacing a homologous region in Kir3.4 [21]. The GLQ-depen-
dent activity of Kir3.1/Kir3.4 channels could be explained in a
way that Kir3.4 has a site for GLQ binding in place of a PIP2
binding site. The presence of additional binding sites may also
confer to a reported speci¢city of Kir2.1 toward PIP2 in con-
trast to Kir3.1/Kir3.4 [6]. Whether this principle can be ex-
tended to other members of the Kir family, such as KATP
channels, will be an important question for future investiga-
tions.
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